0001144204-17-033587.txt : 20170622 0001144204-17-033587.hdr.sgml : 20170622 20170622143319 ACCESSION NUMBER: 0001144204-17-033587 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170622 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TODOS MEDICAL LTD. CENTRAL INDEX KEY: 0001645260 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-209744 FILM NUMBER: 17924848 BUSINESS ADDRESS: STREET 1: 1 HAMADA STREET CITY: REHOVOT STATE: L3 ZIP: 7670301 BUSINESS PHONE: 972546380666 MAIL ADDRESS: STREET 1: 1 HAMADA STREET CITY: REHOVOT STATE: L3 ZIP: 7670301 6-K 1 v469472_6k.htm 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2017

Commission File Number 333-209744

TODOS MEDICAL LTD.

(Translation of registrant's name into English)

1 Hamada Street

Rehovot, Israel

+972-8-633-3964

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

x Form 20-F ¨ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Notice of Allowance of US Patent Application

On June 15, 2017, Todos Medical Ltd. (the “Company”) received a notice of allowance from the United States Patent and Trademark Office (the “PTO”) with regard to US Patent Application 14/116,506, an application regarding analysis of an infrared (“IR”) spectrum of a blood plasma sample to indicate the presence of a solid tumor in the gastrointestinal tract. The issue fee payment is due by September 15, 2017, and the Company expects the patent to issue within two months of the payment of the issue fee. The Company believes the anticipated issuance of this patent is an important milestone in protecting the Company’s technology.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TODOS MEDICAL LTD.


	By:	/s/ Rami Zigdon
		Name: Rami Zigdon
		Title: Chief Executive Officer
Date: June 22, 2017